Bloomberg the Company

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Prosensa Holding NV

+ Add to Watchlist


18.7400 USD 0.0600 0.32%

As of 20:10:00 ET on 01/30/2015.

Company Profile for Prosensa Holding NV (RNA)

Prosensa Holding NV is a biotechnology company engaged in the discovery and development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The Company's primary focus is on neuromuscular and neurodegenerative disorders, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease.

Contact Information

Prosensa Holding NV

JH Oortweg 21
Leiden, NL-2333 CH
Phone: 31-71-33-22-100
Fax: 31-71-33-22-088

Key Executives for Prosensa Holding NV (RNA)

Hans G C P SchikanCEO/Member-Mgmt BoardBerndt A E ModigCFO/Member-Mgmt Board
Willem W Van WeperenChief Commercial OfficerLuc DochezSenior VP:Bus Dev/Chief Bus Ofcr
Giles V CampionSenior VP:R&D/Chief Medical Ofcr

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil